Elevated expression of SLC16A1-AS1 in HCC samples is strongly linked to poor prognosis, including adverse outcomes in overall survival, progression-free survival, and distant metastasis-free survival [100]. This evidence concerns the gene SLC16A1 and hepatocellular carcinoma.